STOCK TITAN

Dolby (NYSE: DLB) CEO shifts 145,252 stock options into family trust

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Dolby Laboratories President and CEO Kevin J. Yeaman, who is also a director, reported an internal transfer of employee stock options rather than a market trade. On February 5, 2026, an option covering 145,252 shares of Dolby Class A common stock with a $66.62 exercise price was moved from his direct ownership to the Kevin and Rachel Yeaman Family Trust, a revocable trust, for no consideration.

The filing notes this change was made for estate planning purposes and is exempt from Section 16(b) under Rule 16b‑5. The option was originally granted for 145,252 shares, with one-quarter vesting on the first anniversary of December 15, 2025 and the remaining shares vesting in equal monthly installments over the subsequent 36 months, and it expires on December 15, 2035.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
YEAMAN KEVIN J

(Last) (First) (Middle)
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET

(Street)
SAN FRANCISCO CA 94103

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Dolby Laboratories, Inc. [ DLB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $66.62 02/05/2026 G(1) 145,252 (2) 12/15/2035 Class A Common Stock 145,252 $0 145,252 D
Employee Stock Option (Right to Buy) $66.62 02/05/2026 G(1) 145,252 (2) 12/15/2035 Class A Common Stock 145,252 $0 145,252 I By a trust(3)
Explanation of Responses:
1. Effective February 5, 2026, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes. This transfer is exempt from Section 16(b) by virtue of Rule 16b-5.
2. This option was granted for a total of 145,252 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter.
3. By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009
/s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman 02/09/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Dolby (DLB) CEO Kevin Yeaman report on this Form 4?

Kevin Yeaman reported transferring an employee stock option covering 145,252 Dolby Class A shares from his direct ownership to a revocable family trust. The move occurred on February 5, 2026, was for estate planning purposes, and involved no consideration, indicating an internal ownership change rather than a market sale.

How many Dolby (DLB) stock options were moved to the Kevin and Rachel Yeaman Family Trust?

An employee stock option over 145,252 shares of Dolby Class A common stock was transferred to the Kevin and Rachel Yeaman Family Trust. The option retains its original terms, including the exercise price and vesting schedule, but the beneficial ownership is now reported as indirect, held by the family trust.

What are the key terms of Kevin Yeaman’s Dolby (DLB) stock option in this filing?

The reported employee stock option covers 145,252 Dolby Class A shares with a $66.62 exercise price and a December 15, 2035 expiration date. It was granted for 145,252 shares in total, with vesting tied to a schedule beginning on the first anniversary of December 15, 2025.

How do the Dolby (DLB) stock options reported by Kevin Yeaman vest over time?

The option vests over four years. One-quarter of the 145,252 underlying shares vests on the first anniversary of December 15, 2025, the vesting commencement date. The remaining three-quarters vest in equal monthly installments over the next 36 months following that first anniversary.

Does this Dolby (DLB) Form 4 show a sale of shares by the CEO?

The Form 4 does not show a market sale of shares. Instead, it records a transfer of an employee stock option to a revocable family trust for no consideration, described as being for estate planning purposes and treated as exempt from Section 16(b) under Rule 16b‑5.

Who now holds the Dolby (DLB) options reported in Kevin Yeaman’s Form 4?

Following the February 5, 2026 transaction, the employee stock option is reported as held indirectly by the Kevin and Rachel Yeaman Family Trust. The filing identifies this revocable trust explicitly, noting the transfer for estate planning purposes and continuing to show 145,252 derivative securities beneficially owned.
Dolby Laboratories Inc

NYSE:DLB

DLB Rankings

DLB Latest News

DLB Latest SEC Filings

DLB Stock Data

6.20B
59.96M
1.35%
98.06%
1.9%
Specialty Business Services
Patent Owners & Lessors
Link
United States
SAN FRANCISCO